HIV-AIDS | Microbicide Trials Network

From Criminalization to Compassion: The Evolution of HIV Laws - AJMC.com Managed Markets Network

Wed, 10/02/2024 - 14:33

Dr. Reddy’s, Hetero ink deal with Gilead to make, market generic HIV drug lenacapavir - The Hindu

Wed, 10/02/2024 - 14:12

Indian pharma firms ink deal with U.S. drug maker Gilead to make, market generic HIV drug lenacapavir - The Hindu

Wed, 10/02/2024 - 14:12

Are we on the path to end AIDS by 2030? - Modern Ghana

Wed, 10/02/2024 - 13:22

Debbie Allen Reflects On Losing Half Of Her Dance Company To The AIDS Epidemic - 107.5 WBLS

Wed, 10/02/2024 - 13:00

Dr Reddy's, Hetero sign voluntary licenses with Gilead for HIV drug - Business Standard

Wed, 10/02/2024 - 12:03

Watch HIV.gov at USCHA 2024: A Syndemic of Syphilis, Substance Use and HIV - POZ

Wed, 10/02/2024 - 11:33

US’s $100 Billion HIV Program Commits to African Manufacturing - Bloomberg Law

Wed, 10/02/2024 - 11:02

Hetero Signs Voluntary Licensing Agreement with Gilead to Transform Global HIV response, Expanding Access to Groundbreaking Lenacapavir to 120 high-incidence countries - Yahoo Finance

Wed, 10/02/2024 - 10:52

Gilead strikes deal to rush HIV prevention drug to countries most in need - The Business Journals

Wed, 10/02/2024 - 10:45

Dr Reddy's ties up with Gilead to manufacture, commercialise HIV drug - Business Standard

Wed, 10/02/2024 - 10:35

Hetero Signs Voluntary Licensing Agreement with Gilead to Transform Global HIV response, Expanding Access to Groundbreaking Lenacapavir to 120 high-incidence countries - Yahoo Finance

Wed, 10/02/2024 - 10:34

Hetero Signs Voluntary Licensing Agreement with Gilead to Transform Global HIV response, Expanding Access to Groundbreaking Lenacapavir to 120 high-incidence countries - PR Newswire

Wed, 10/02/2024 - 10:34

Hetero Signs Voluntary Licensing Agreement with Gilead to Transform Global HIV response, Expanding Access to Groundbreaking Lenacapavir to 120 high-incidence countries - StockTitan

Wed, 10/02/2024 - 10:34

Debbie Allen Opens Up About Losing Half of Her Dance Company During the AIDS Crisis - BET

Wed, 10/02/2024 - 10:05

Corporate Accountability and Public Health: Sackler Ruling and Treatment Gaps in the Opioid Crisis - AJMC.com Managed Markets Network

Wed, 10/02/2024 - 09:30

Gilead Signs Royalty-Free Voluntary Licensing Agreements With Six Generic Manufacturers to Increase Access to Lenacapavir for HIV Prevention in High-Incidence, Resource-Limited Countries - Business Wire

Wed, 10/02/2024 - 08:30

Remembering gay Hollywood icon Rock Hudson 39 years after his tragic death - PinkNews

Wed, 10/02/2024 - 07:35

HIV incidence and its associated factors among young adults with multiple sexual partners in Maputo, Mozambique: a vaccine preparedness study - BMC Public Health

Wed, 10/02/2024 - 05:22

Being Alive to Open Harm Reduction Drop-In Center in West Hollywood - WEHO TIMES

Wed, 10/02/2024 - 05:10

Defining the Goals of HIV Science Through 2034 - HIV.gov

Wed, 10/02/2024 - 03:00

South Africa: Couple Receives Prestigious Award for HIV/AIDS Work - South African News Briefs - October 2, 2024 - AllAfrica - Top Africa News

Wed, 10/02/2024 - 02:34

Why has progress against HIV stalled among Hispanic & Latino Americans? - Queerty

Tue, 10/01/2024 - 22:00

R.I.P. Author Tom Spanbauer, Who Wrote of Gay Life, Family and HIV - POZ

Tue, 10/01/2024 - 19:57

Gilead and the Community Education Group are centering Appalachian voices at USCHA - Los Angeles Blade

Tue, 10/01/2024 - 18:18

NEW: Medicare Part B Coverage of Pre-exposure Prophylaxis (PrEP) for HIV Prevention - HIV.gov

Tue, 10/01/2024 - 14:56

AIDS Walk Delaware continues international effort - CapeGazette.com

Tue, 10/01/2024 - 14:08

Migrants fuel surge in HIV cases to 15-year high - The Telegraph

Tue, 10/01/2024 - 12:42

Progress To End AIDS In Georgia ‘Threatened’ By New Anti-LGBTQ+ Law - Health Policy Watch

Tue, 10/01/2024 - 12:17

Alarm as HIV soars by a third in heterosexual Brits in just one year... and the intriguing reasons why - Daily Mail

Tue, 10/01/2024 - 12:08